口蹄疫疫苗市场：依疫苗类型、动物类型和地区划分

2025年全球口蹄疫疫苗市场规模估计为31.5亿美元，预计2032年将达到56.6亿美元，2025年至2032年的复合年增长率为8.7%。

数字。 2025 年口蹄疫疫苗市场占有率（按地区划分）

口蹄疫（FMD）是一种高度传染性的病毒性疾病，影响有蹄动物，包括牛、猪、羊、山羊、鹿和其他牲畜。该疾病造成了严重损害，包括直接造成牛奶产量和受感染动物的生长损失，以及因控制、治疗和贸易限製而造成的间接经济损失。口蹄疫在亚洲、非洲和南美洲部分地区流行，这些地区正在进行紧急疫苗接种工作以控制疫情。国际贸易和牲畜流动的增加使口蹄疫控制更具挑战性，需要改善疫苗接种策略和干预措施。

市场动态

全球口蹄疫疫苗市场的成长受到多种因素的推动，例如牲畜口蹄疫流行率的上升、气候和农业实践变化导致的全球疫情扩大以及动物和动物产品的国际贸易。然而，疫苗生产、储存和设备重复使用相关的高成本可能会阻碍市场成长。此外，各国疫苗核准监管指南缺乏标准化也阻碍了市场的成长。分子生物学技术的机会发展，使得开发具有更高免疫抗原性和交叉保护能力的新一代疫苗成为可能，这可能为市场成长提供机会。人们对先前无口蹄疫的国家控制口蹄疫的兴趣日益浓厚，这可能会开闢新的应用领域。

研究的主要特点

• 本报告对全球口蹄疫疫苗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球口蹄疫疫苗市场的主要企业概况。
• 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球口蹄疫疫苗市场报告针对该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员将透过全球口蹄疫疫苗市场分析中使用的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球口蹄疫疫苗市场-冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球口蹄疫疫苗市场（按疫苗类型划分）（十亿美元）

• 介绍
• 常规疫苗
• 氢氧化铝疫苗
• 油性疫苗
• 紧急疫苗

6. 2020 年至 2032 年全球口蹄疫疫苗市场（按动物类型划分）（十亿美元）

• 介绍
• 牛
• 绵羊和山羊
• 猪
• 其他的

7. 2020 年至 2032 年全球口蹄疫疫苗市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• 公司简介
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.（MSD Animal Health）
  • Indian Immunologicals Ltd.
  • Limber Laboratories Pvt. Ltd.
  • Brilliant Bio Pharma Private Limited
  • Inova BIoTechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica SA
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI-Federal Centre for Animal Health
  • Vecol SA
  • Laboratorios Agrovet SA
  • Centro Diagnostico Veterinario
  • Razi Vaccine & Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

第 9 章分析师建议

• 兴衰
• 一致的机会地图

第十章参考文献与调查方法

• 参考
• 调查方法

Global Foot And Mouth Disease Vaccine Market is estimated to be valued at USD 3.15 Bn in 2025 and is expected to reach USD 5.66 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Figure. Foot And Mouth Disease Vaccine Market Share (%), By Region 2025

Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals including cattle, pigs, sheep, goats, deer and other livestock. The disease can cause severe damage both direct loss in milk yield and growth in infected animals and indirect economic losses from control, treatment and trade restrictions. FMD is a endemic in parts of Asia, Africa, and South America where emergency vaccination is practiced to control outbreaks. With growing international trade and movement of livestock, controlling FMD has become more challenging, thus, requiring improved vaccination strategies and interventions.

Market Dynamics:

Global foot and mouth disease vaccine market growth is driven by factors such as increasing prevalence of FMD amongst livestock, growing outbreaks worldwide due to changes in climate and farming practices as well as international trade in animals and animal products. However, high costs associated with vaccine production and storage and reuse of equipment can hamper the market growth. Furthermore, lack of standardized regulatory guidelines for vaccine approval in different countries also hampers the market growth. Advancements in molecular biological techniques that enables development of new generation vaccines with improved immunogenicity and cross-protection can offer market growth opportunity. Growing focus on controlling FMD in previously FMD-free countries can open new application areas.

Key Features of the Study:

• This report provides in-depth analysis of the global foot and mouth disease vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global foot and mouth disease vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Biogenesis Bago, Indian Immunologicals Ltd., Boehringer Ingelheim, Vetal Animal Health
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation

• By Vaccine Type:
  • Conventional Vaccine
  • Aluminum Hydroxide based vaccine
  • Oil based vaccines
  • Emergency Vaccines
• By Animal Type
  • Cattle
  • Sheep and Goat
  • Swine
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc. (MSD Animal Health)
  • Indian Immunologicals Ltd.
  • Limber Laboratories Pvt. Ltd.
  • Brilliant Bio Pharma Private Limited
  • Inova Biotechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica S.A.
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI - Federal Centre for Animal Health
  • Vecol S.A.
  • Laboratorios Agrovet S.A.
  • Centro Diagnostico Veterinario
  • Razi Vaccine & Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Foot and Mouth Disease Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Foot and Mouth Disease Vaccine Market, By Vaccine Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Conventional Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Aluminum Hydroxide based vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oil based Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Emergency Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Foot and Mouth Disease Vaccine Market, By Animal Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cattle
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sheep and Goat
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Swine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Foot and Mouth Disease Vaccine Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc. (MSD Animal Health)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Indian Immunologicals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Limber Laboratories Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Brilliant Bio Pharma Private Limited
  • Inova Biotechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica S.A.
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI - Federal Centre for Animal Health
  • Vecol S.A.
  • Laboratorios Agrovet S.A.
  • Centro Diagnostico Veterinario
  • Razi Vaccine & Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact